News | Kneu Health

Skip to main content

How it works NHS Parkinson’s disease Dementia

Company

About
How it works
Our science
News

Services

Parkinsons
Dementia
NHS

Legal

Cookie Policy
Privacy Policy
Terms of Use

Contact & Support

Request a demo
General enquiries
Patients Support
Frequently Asked Questions

Follow us on Social media

Kneu Health is a MHRA registered and FDA cleared medical device.

Kneu Health Ltd is registered in England and Wales with company number 14492037 and its registered office is at First Floor, 100 Victoria Embankment, London, EC4Y 0DH, United Kingdom. It is registered under the Data Protection Act No. ZB541090. U.S. Patent No. 12,569,185. © 2026 Kneu Health Ltd. All rights reserved.

FilterCompany news Partnerships Impact Platform updates Perspectives

Company news

Kneu Health Secures $5.6M to Scale Next-Generation Neurology Care

9 October 2025

Company news | Partnerships

Kneu Health Joins Global Incubator Programme: Advancing Precision Neurology for Parkinson's and Dementia Care in Texas

12 September 2025

Company news

Kneu Health Launches in U.S

29 July 2025

Company news | Partnerships

Kneu Health joins the Alzheimer's Society Accelerator

6 June 2025

Company news

Kneu Health Secures $2 Million Investment from Cedars-Sinai and Oxford Science Enterprises to Revolutionise Neurology Care

29 January 2025

Impact | Company news

Kneu Health Celebrates HSJ Awards Win for Digitising Patient Care

22 November 2024

Company news | Platform updates

Kneu Health Now Available on G-Cloud 14: Making Parkinson's and Dementia Care Accessible For All

31 October 2024

Company news | Impact

Kneu Health, ESNEFT & Health Innovation East Shortlisted for the 2024 HSJ Awards, Setting a New Standard for Healthcare Excellence

12 August 2024

Company news | Partnerships

Kneu Health Joins Cedars-Sinai Accelerator to Revolutionise Parkinson's Disease and Dementia in the US

2 August 2024

Showing 10–18 of 25 results